A Single Intravesical Instillation of VAX014 Inhibits Orthotopic Superficial Bladder Tumor Implantation to Increase Survival

VAX014 minicells (VAX014) have been previously characterized as an integrin-specific oncolytic biotherapeutic agent. The present study was designed to evaluate the potential of VAX014 as an immediate post-operative intravesical adjuvant therapy in the treatment of non-muscle invasive bladder cancer...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Anticancer research 2016-12, Vol.36 (12), p.6243-6248
Hauptverfasser:	Hancock, Bryan M, McGuire, Kathleen L, Tsuji, Shingo, Reil, Katherine, Hernandez, Veronica, Giacalone, Matthew J, Godbey, W T
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Cancer Vaccines - administration & dosage Cell Line, Tumor Humans Mice Survival Rate Urinary Bladder Neoplasms - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!